SMEDDS of Citrus hystrix ethanolic extract improves cardiac and hepar histopathology profile on doxorubicin-induced rats

Dhania Novitasari, Prisnu Tirtanirmala, Nindi Wulandari, Layung Sekar Sih Wikanthi, Ade Safitri, Ediati Sasmito

Abstract


Citrus hystrix D.C. (kaffir lime) peel contains several flavonoids including rutin, naringenin, hesperidin. C. hystrix peel ethanolic extract (ChEE) has shown its potency as cardioprotector agent in chemotherapy. However, there  are  limitations  to  the  utilization  of  ChEE due to its  poor  water  solubility  and  low  oral bioavailability.  Accordingly,  self-microemulsifying drug delivery system (SMEDDS) formulations were developed to improve the oral absorption of flavonoids. Tween 80, Corn oil, and propylene glicol (5:1:1ml) were combined to form ChEE-SMEDDS. The present study is to evaluated ChEE-SMEDDS for their physicochemical  properties and in vivo using combination with doxorubicin to see blood serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), nitrit oxide (NO) activity and also cardio-hepato-histopathology of female Sprague Dawley rats. The results showed that ChEE-SMEDDS repaired cardio-hepato-histopathology profile of doxorubicin -induced rats, but did not reduce serum activity of NO, ALT and AST. These  results indicated that ChEE-SMEDDS has potency to be developed and improved as cardio-hepato-protector agent in chemotherapy.

Keywords: Citrus hystrix D.C., SMEDDS, Cardio-hepatoprotector, Histopathology, Chemoterapy


Full Text:

PDF

References


Ampasavate, C., Okonogi, S. and Anuchapreeda, S., 2010, Cytotoxicity of Extracts From Fruit Plants Against Leukemic Cell Lines, Afr. J. Pharm. Pharmacol.,4(1), 13-21. Link

Anandakumar, P.P., Malarkodi, S.P., Sivaprasad, T.R. and Saravanan, G.D., 2007, Antioxidant DL-Alpha Lipoic Acid as an Attenuator of Adriamycin Induced Hepatotoxicity in Rat Model, Indian J. Exp. Biol.,45(12), 1045-1049. Link

Arafa, H.M., Abd-Ellah, M.F. and Hafez, H.F., 2005, Abatement by Naringenin of Doxorubicin-Induced Cardiac Toxicity in Rats, J. Egypt Natl. Canc. Inst., 17(4), 291-300. Link

Bisset, N.G. and Wichtl, M., 1994, Herbal Drug and Phytopharmaseuticals, Medpharm GmbH Scientific Publishers, Tokyo, 151-152.

Brilhante Wolle, C.F., de Aguiar Zollmann, L., Etges, A., Vitalis, G.S., Leite, C.E. and Campos, M.M., 2012, Effects of the Antioxidant Agent Tempol on Periapical Lesions in Rats with Doxorubicininduced Cardiomyopathy, J. Endod., 38(2), 191-195. CrossRef

El-Sayyad, H.I., Ismail, M.F., Shalaby, F.M., Abou-El-Magd, R.F., Gaur, R.L., Fernando, A., et al., 2009,Histopathological Effects of Cisplatin, Doxorubicin and 5-Flurouracil (5-FU) on the Liver of Male Albino Rats, Int. J. Biol. Sci., 5(5), 466-473. Link

Gille, L. and Nohl, H., 1997, Analysesof the Molecular Mechanism of Adriamycin-Induced Cardiotoxicity, Free Radic. Biol. Med., 23(5), 775-782. Link

Gursoy, R.N. and Benita, S., 2004, Self-emulsifying Drug Delivery Systems (SEDDS) for Improved Oral Delivery of Lipophilic Drugs, Biomed. Pharmacother., 58(3), 173–182. CrossRef

Hardina, R., Gersl, V., Klimtova, I., et al., 2000, Anthracycline induced cardiotoxicity [J], Acta Medica, 43(6), 75-82.

Hauss, D.J., 2007, Oral Lipid-based Formulations, Adv. Drug Deliv. Rev ., 59(7), 667–676. CrossRef

Henninger, C., Huelsenbeck, J., Huelsenbeck, S., Grösch, S., Schad, A., Lackner, K.J., et al., 2012, The Lipid Lowering Drug Lovastatin Protects Against Doxorubicin-induced Hepatotoxicity, Toxicol Appl. Pharmacol., 261(1), 66-73. Link

Ishibashi, Y., Takahashi, N., Tokumaru, A., Karino, K., Sugamori, T., Sakane, T., et al., 2008, Activation of Inducible NOS in Peripheral Vessels and Outcomes in Heart Failure Patients, J. Card. Fail., 14(9), 724-731. CrossRef

Jiang, B., Zhang, L., Wang, Y., Li, M., Wu, W., Guan, S., et al., 2009, Tanshinone IIA Sodium Sulfonate Protects Against Cardiotoxicity Induced by Doxorubicin In Vitro and In Vivo, Food Chem. Toxicol., 47(7), 1538-1544. CrossRef

Kawaguchi, K., Kikuchi, S., Hasegawa, H., Maruyama, H., Morita, H., Kumazawa, Y., 2009, Suppression of Lipopolysaccharide-induced Tumor Necrosis Factor- Release and Liver Injury in Mice by Naringenin, Eur. J. Pharm., 368(2-3), 245–250. CrossRef

Li, R., Li, J., Hu, C., Zhang, L. and Zhang, Q., 2007, Immuno-modulative Effect of Hesperidin on Immuno-depressed Mice, Chinese Pharmacol. Bull., 23(2), 169-172.

Patel, D. and Sawant, K.K., 2007, Oral Bioavailability Enhancement of Acyclovir by Self-microemulsifying Drug Delivery Systems (SMEDDS), Drug Dev. Ind. Pharm., 33(12), 1318–1326. CrossRef

Pouton, C.W., 2000, Lipid Formulations for Oral Administration of Drugs: Non-Emulsifying, ‘Self Emulsifying and Self-Microemulsifying’ Drug Delivery Systems, Eur. J. Pharm. Sci., 11(2), S93-S98. Link

Punithavathi, V.R., Shanmugapriya, K. and Prince, P.S., 2010, Protective Effects of Rutin on Mitochondrial Damage in Isoproterenol-Induced Cardiotoxic Rats: An In Vivo and In Vitro Study, Cardiovasc.Toxicol., 10(3),181–189. CrossRef

Putri, H., Nagadi, S., Larasati, Y.A., Wulandari, N., Hermawan, A. and Nugroho, A.E., 2013, Cardioprotective and Hepatoprotective Effects of Citrus hystrix Peels Extract on Rats Models, Asian Pac. J. Trop. Biomed., 3(5), 371–375. CrossRef

Sachan, R., Khatri, K. and Kasture, S.B., 2010, Self-emulsifying Drug Delivery System a Novel Approach for Enhancement of Bioavailability, Int. J. PharmTech. Res, 2, 1738–1745.

Simůnek T, Stérba M, Popelová O, Adamcová M, Hrdina R, Gersl V. Anthracycline -induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron, Pharmacol. Rep., 61(1), 154-171.

Solanki, S.S., Sarkar, B. and Dhanwani, R.K., 2012, Microemulsion Drug Delivery System: For Bioavailability Enhancement of Ampelopsin, ISRN Pharm., 2012, 108164. CrossRef

Takacs, I.E., Matkovics, B., Varga, S.I., et al., 1992, Study of the Myocardial Antioxidant Defense in Various Species [J], Pharmacol. Res., 25(6), 177-178.

Tirkey, N., Pilkhwal, S., Kuhad, A. and Chopra, K., 2005, Hesperidin, a Citrus Bioflavonoid, Decreases the Oxidative Stress Produced by Carbon Tetrachloride in Rat Liver and Kidney, BMC Pharmacol., 5, 2. CrossRef




DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev6iss3pp97-104

Copyright (c) 2017 Indonesian Journal of Cancer Chemoprevention

Indexed by:

               

               

      

 

Indonesian Society for Cancer Chemoprevention